These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 21267522

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Severely frail elderly patients do not need lipid-lowering drugs.
    Mallery LH, Moorhouse P, McLean Veysey P, Allen M, Fleming I.
    Cleve Clin J Med; 2017 Feb; 84(2):131-142. PubMed ID: 28198686
    [Abstract] [Full Text] [Related]

  • 4. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG, Tissot CM.
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract] [Full Text] [Related]

  • 5. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY, Ko SK, Liew D.
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [Abstract] [Full Text] [Related]

  • 6. JCL roundtable: lipid-lowering drugs in those older than 75 years of age.
    Brown WV, Bittner VA, McKenney JM, Ziajka PE.
    J Clin Lipidol; 2014 Dec; 8(6):533-541. PubMed ID: 25499934
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic therapy of lipid disorders in the elderly.
    Aronow WS.
    Am J Geriatr Cardiol; 2002 Dec; 11(4):247-56. PubMed ID: 12091773
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emerging drugs for hyperlipidaemia: an update.
    Florentin M, Kostapanos MS, Kei A, Elisaf MS.
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):471-88. PubMed ID: 25356785
    [Abstract] [Full Text] [Related]

  • 13. Lipid lowering for secondary prevention of cardiovascular disease in older adults.
    Thomas JE, Tershakovec AM, Jones-Burton C, Sayeed RA, Foody JM.
    Drugs Aging; 2010 Dec 01; 27(12):959-72. PubMed ID: 21087066
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Primary prevention of cardiovascular disease with statins in the elderly.
    Reiner Z.
    Curr Atheroscler Rep; 2014 Jul 01; 16(7):420. PubMed ID: 24781597
    [Abstract] [Full Text] [Related]

  • 17. The analysis by Manuel and colleagues creates controversy with headlines, not data.
    Genest J, McPherson R, Frohlich J, Fodor G.
    CMAJ; 2005 Apr 12; 172(8):1033-4; discussion 1037. PubMed ID: 15824410
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological management of dyslipidemia in high and very high cardiovascular risk patients.
    Pascual Fuster V.
    Rev Esp Sanid Penit; 2016 Dec 12; 18(3):95-108. PubMed ID: 27831597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.